MetaADEDB 2.0 @ LMMD
betamethasone-17,21-dipropionate
(CIWBQSYVNNPZIQ-XYWKZLDCSA-N)
Structure
SMILES
CCC(=O)O[C@@]1([C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)F)C(=O)COC(=O)CC
Molecular Formula:
C28H37FO7
Molecular Weight:
504.588
Log P:
3.8175
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
1
TPSA:
106.97
CAS Number(s):
5593-20-4
Synonym(s)
1.
betamethasone-17,21-dipropionate
2.
Beloderm
3.
Diprolene
4.
Diprosone
5.
Maxivate
6.
augmented betamethasone dipropionate
7.
betamethasone dipropionate
8.
betamethasone propionate
External Link(s)
MeSHC011175
PubChem Compound21800
BindingDB50421892
ChEBI31276
CHEMBLCHEMBL1200384
DrugCentral353
KEGGdr:D01637
ZINC4212137
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 41US FAERS
2Incorrect route of drug administrationFAERS: 20US FAERS
3Product use issueFAERS: 17US FAERS
4Drug prescribing errorFAERS: 16US FAERS
5Drug administered to patient of inappropriate ageFAERS: 13US FAERS
6Product use in unapproved indicationFAERS: 9US FAERS
7Maternal exposure during pregnancyFAERS: 8US FAERS
8Product quality issueFAERS: 7US FAERS
9Wrong technique in product usage processFAERS: 7US FAERS
10ErythemaFAERS: 6
Canada Vigilance: 1		Canada Vigilance
OFFSIDES
US FAERS
11Eye irritationFAERS: 6US FAERS
12Medication ErrorFAERS: 6US FAERS
13No adverse eventFAERS: 6US FAERS
14PruritusFAERS: 6US FAERS
15HypersensitivityFAERS: 5US FAERS
16Incorrect route of product administrationFAERS: 5US FAERS
17PsoriasisFAERS: 53891239CTD
OFFSIDES
US FAERS
18Anaphylactic shockFAERS: 4US FAERS
19Burning sensationFAERS: 4US FAERS
20Drug ineffective for unapproved indicationFAERS: 4US FAERS
21Expired product administeredFAERS: 4US FAERS
22Eye painFAERS: 4US FAERS
23Adverse eventFAERS: 3US FAERS
24Application site painFAERS: 3US FAERS
25Application site pruritusFAERS: 3US FAERS
26Drug dispensing errorFAERS: 3US FAERS
27Drug dose omissionFAERS: 3US FAERS
28Feeling abnormalFAERS: 3US FAERS
29Product packaging quantity issueFAERS: 3US FAERS
30Product physical consistency issueFAERS: 3US FAERS
31Abdominal PainFAERS: 2US FAERS
32AcarodermatitisFAERS: 2US FAERS
33Accidental exposure to productFAERS: 2US FAERS
34AlopeciaFAERS: 2OFFSIDES
US FAERS
35Application site rashFAERS: 2US FAERS
36CellulitisFAERS: 2OFFSIDES
US FAERS
37EczemaFAERS: 215550136CTD
OFFSIDES
US FAERS
38FatigueFAERS: 2US FAERS
39GlaucomaFAERS: 215550136CTD
OFFSIDES
US FAERS
40Inappropriate schedule of drug administrationFAERS: 2US FAERS
41Incorrect dose administeredFAERS: 2US FAERS
42MalaiseFAERS: 2US FAERS
43ObesityFAERS: 2US FAERS
44Optic NeuropathyFAERS: 2OFFSIDES
US FAERS
45PalpitationsFAERS: 2US FAERS
46Product prescribing errorFAERS: 2US FAERS
47RosaceaFAERS: 2US FAERS
48Therapeutic response unexpectedFAERS: 2US FAERS
49UrticariaFAERS: 2US FAERS
50Wrong drug administeredFAERS: 2US FAERS
51AcneFAERS: 1US FAERS
52Acute kidney injuryFAERS: 1US FAERS
53AgitationFAERS: 1US FAERS
54AngerFAERS: 1US FAERS
55AngioedemaFAERS: 1US FAERS
56AnuriaFAERS: 1US FAERS
57AphasiaFAERS: 1US FAERS
58Application site acneFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
59Application site alopeciaFAERS: 1US FAERS
60Application site dischargeFAERS: 1US FAERS
61Application site erythemaFAERS: 1US FAERS
62Application site lacerationFAERS: 1US FAERS
63Application site swellingFAERS: 1US FAERS
64AsphyxiaFAERS: 1US FAERS
65Blood alkaline phosphatase increasedFAERS: 1OFFSIDES
US FAERS
66Blood glucose increasedFAERS: 1US FAERS
67Blood sodium decreasedFAERS: 1US FAERS
68Blood triglycerides increasedFAERS: 1US FAERS
69Bronchial ObstructionFAERS: 1US FAERS
70Cardiac dysfunctionFAERS: 1US FAERS
71Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
72ClumsinessFAERS: 1US FAERS
73CryingFAERS: 1US FAERS
74DeafnessFAERS: 1US FAERS
75DermatitisFAERS: 1US FAERS
76Diabetes MellitusFAERS: 1US FAERS
77Disseminated Intravascular CoagulationFAERS: 1US FAERS
78Drug administration errorFAERS: 1US FAERS
79Drug effect delayedFAERS: 1US FAERS
80Drug effective for unapproved indicationFAERS: 1US FAERS
81Dry skinFAERS: 1US FAERS
82DysgeusiaFAERS: 1US FAERS
83DysphoniaFAERS: 1US FAERS
84Elevated moodFAERS: 1US FAERS
85Exposure via direct contactFAERS: 1US FAERS
86Eye inflammationFAERS: 1US FAERS
87Failure to ThriveFAERS: 1US FAERS
88Feeling ColdFAERS: 1US FAERS
89Feeling jitteryFAERS: 1US FAERS
90FibromyalgiaFAERS: 1US FAERS
91Frustration tolerance decreasedFAERS: 1US FAERS
92Growth retardationFAERS: 1US FAERS
93Head circumference abnormalFAERS: 1US FAERS
94HeadacheFAERS: 1US FAERS
95HirsutismFAERS: 1US FAERS
96HypertrichosisFAERS: 1US FAERS
97Hypertrophic CardiomyopathyFAERS: 1US FAERS
98HypogeusiaFAERS: 1US FAERS
99ImmunosuppressionFAERS: 1US FAERS
100Inability to afford medicationFAERS: 1US FAERS
101Inappropriate schedule of product administrationFAERS: 1US FAERS
102Incorrect product storageFAERS: 1US FAERS
103InflammationFAERS: 1US FAERS
104Intentional product misuseFAERS: 1US FAERS
105Limb injuryFAERS: 1US FAERS
106LipohypertrophyFAERS: 1US FAERS
107Low birth weight babyFAERS: 1US FAERS
108MenorrhagiaFAERS: 1US FAERS
109Mental FatigueFAERS: 1US FAERS
110Metabolic acidosisFAERS: 1OFFSIDES
US FAERS
111Middle insomniaFAERS: 1US FAERS
112Mucocutaneous candidiasisFAERS: 1US FAERS
113NasopharyngitisFAERS: 1US FAERS
114NauseaFAERS: 1US FAERS
115NoduleFAERS: 1US FAERS
116OliguriaFAERS: 1US FAERS
117OsteochondrosisFAERS: 1US FAERS
118OverdoseFAERS: 1OFFSIDES
US FAERS
119PainFAERS: 1US FAERS
120Pharmaceutical product complaintFAERS: 1US FAERS
121Pityriasis Rubra PilarisFAERS: 1US FAERS
122Placental InsufficiencyFAERS: 1US FAERS
123Pneumocystis jiroveci pneumoniaFAERS: 1OFFSIDES
US FAERS
124Poor peripheral circulationFAERS: 1US FAERS
125Pre-EclampsiaFAERS: 1US FAERS
126Product administered at inappropriate siteFAERS: 1US FAERS
127Product administered to patient of inappropriate ageFAERS: 1US FAERS
128Product appearance confusionFAERS: 1US FAERS
129Product label confusionFAERS: 1US FAERS
130Product packaging issueFAERS: 1US FAERS
131Product physical issueFAERS: 1US FAERS
132Product prescribing issueFAERS: 1US FAERS
133Product substitution issueFAERS: 1US FAERS
134Pulmonary EmbolismFAERS: 1US FAERS
135PurpuraFAERS: 1US FAERS
136Respiratory FailureFAERS: 1US FAERS
137Respiratory distressFAERS: 1US FAERS
138Sjogren's SyndromeFAERS: 1US FAERS
139Skin adhesionFAERS: 1US FAERS
140Small size placentaFAERS: 1US FAERS
141TachycardiaFAERS: 1US FAERS
142Therapeutic response unexpected with drug substitutionFAERS: 1US FAERS
143Therapy cessationFAERS: 1US FAERS
144TinnitusFAERS: 1US FAERS
145TremorFAERS: 1US FAERS
146Unevaluable eventFAERS: 1US FAERS
147Unintentional use for unapproved indicationFAERS: 1US FAERS
148Urinary RetentionFAERS: 1US FAERS
149Urinary tract infectionFAERS: 1US FAERS
150VitiligoFAERS: 1US FAERS
151VomitingFAERS: 1US FAERS
152Wrong product administeredFAERS: 1US FAERS
153Abdominal discomfortOFFSIDES
154Acid refluxOFFSIDES
155Actinic keratosisOFFSIDES
156Acute Coronary SyndromeOFFSIDES
157Acute respiratory failureOFFSIDES
158Acute sinusitisOFFSIDES
159Adnexa uteri massOFFSIDES
160Alanine Aminotransferase IncreasedOFFSIDES
161Allergy to arthropod stingOFFSIDES
162Anal abscessOFFSIDES
163AneurysmOFFSIDES
164Anti-platelet antibody positiveOFFSIDES
165ApathyOFFSIDES
166ApneaOFFSIDES
167Arterial thrombosisOFFSIDES
168ArteriosclerosisOFFSIDES
169ArthritisOFFSIDES
170Aspiration PneumoniaOFFSIDES
171AstheniaOFFSIDES
172AstrocytomaOFFSIDES
173Atrioventricular BlockOFFSIDES
174Autoimmune thyroiditisOFFSIDES
175Band neutrophil percentage increasedOFFSIDES
176Basal cell carcinomaOFFSIDES
177BiopsyOFFSIDES
178Blood GlucoseOFFSIDES
179Blood cholesterolOFFSIDES
180Blood corticotrophinOFFSIDES
181Blood glucose decreasedOFFSIDES
182Blood ketone body decreasedOFFSIDES
183Blood lactate dehydrogenase increasedOFFSIDES
184Blood potassium increasedOFFSIDES
185Blood sodiumOFFSIDES
186Bone lesionOFFSIDES
187Bone scan abnormalOFFSIDES
188Brain DeathOFFSIDES
189BronchitisOFFSIDES
190BronchopneumoniaOFFSIDES
191Bullous impetigoOFFSIDES
192Bullous lung diseaseOFFSIDES
193CalcinosisOFFSIDES
194CataractOFFSIDES
195CheilitisOFFSIDES
196Choking sensationOFFSIDES
197Chronic sinusitisOFFSIDES
198Chronic ulcerative colitisOFFSIDES
199Cold sweatOFFSIDES
200ColitisOFFSIDES
201Compression fractureOFFSIDES
202Conjunctival depositOFFSIDES
203Contact DermatitisOFFSIDES
204Denture wearerOFFSIDES
205Dermatitis, Allergic Contact8462297CTD
206Device occlusionOFFSIDES
207DiplopiaOFFSIDES
208Disease recurrenceOFFSIDES
209Drug toxicityOFFSIDES
210DyspepsiaOFFSIDES
211Dysthymic DisorderOFFSIDES
212Electrocardiogram ST segment abnormalOFFSIDES
213Electromechanical dissociationOFFSIDES
214Embolic strokeOFFSIDES
215Emotional disorderOFFSIDES
216EnchondromatosisOFFSIDES
217EpistaxisOFFSIDES
218Erectile dysfunctionOFFSIDES
219Erythrodermic psoriasisOFFSIDES
220Escherichia infectionOFFSIDES
221Escherichia urinary tract infectionOFFSIDES
222ExophthalmosOFFSIDES
223Eye InfectionOFFSIDES
224Facial Dermatoses15550136CTD
225Fistula repairOFFSIDES
226FolliculitisOFFSIDES
227General physical health deteriorationOFFSIDES
228GlossitisOFFSIDES
229GoiterOFFSIDES
230GranulocytosisOFFSIDES
231GranulomaOFFSIDES
232HistoplasmosisOFFSIDES
233HyperkeratosisOFFSIDES
234HyperpigmentationOFFSIDES
235HyperventilationOFFSIDES
236ImpetigoOFFSIDES
237InfectionOFFSIDES
238Injection site erythemaOFFSIDES
239Intention tremorOFFSIDES
240IntertrigoOFFSIDES
241Intervertebral Disc DegenerationOFFSIDES
242Joint Range of Motion DecreasedOFFSIDES
243Keratitis siccaOFFSIDES
244Kidney FailureOFFSIDES
245Lactate pyruvate ratio increasedOFFSIDES
246Lumbar radiculopathyOFFSIDES
247Lung AbscessOFFSIDES
248LymphomaOFFSIDES
249MacrocytosisOFFSIDES
250Maxillofacial operationOFFSIDES
251Mesothelioma malignant advancedOFFSIDES
252Multiple sclerosis relapseOFFSIDES
253Muscle WeaknessOFFSIDES
254Muscle necrosisOFFSIDES
255Muscle strainOFFSIDES
256Musculoskeletal chest painOFFSIDES
257Myoclonus10743834CTD
258Nephritic syndromeOFFSIDES
259Nephrogenic Fibrosing DermopathyOFFSIDES
260NeurodermatitisOFFSIDES
261Ocular icterusOFFSIDES
262Oral fungal infectionOFFSIDES
263Oral polypectomyOFFSIDES
264Oral pruritusOFFSIDES
265Oroantral FistulaOFFSIDES
266OrthopneaOFFSIDES
267OsteomyelitisOFFSIDES
268OsteopeniaOFFSIDES
269OsteoporosisOFFSIDES
270OsteosclerosisOFFSIDES
271ParakeratosisOFFSIDES
272Pathogen resistanceOFFSIDES
273PhlebitisOFFSIDES
274PhotodermatosisOFFSIDES
275PleurisyOFFSIDES
276PneumothoraxOFFSIDES
277Positron emission tomogram abnormalOFFSIDES
278ProctitisOFFSIDES
279Prothrombin level decreasedOFFSIDES
280Pustular psoriasisOFFSIDES
281RalesOFFSIDES
282Rebound effectOFFSIDES
283Renal lipomatosisOFFSIDES
284Renal massOFFSIDES
285Renal tubular acidosisOFFSIDES
286RhabdomyolysisOFFSIDES
287RhinitisOFFSIDES
288Ruptured cerebral aneurysmOFFSIDES
289SarcoidosisOFFSIDES
290ScotomaOFFSIDES
291SeromaOFFSIDES
292Sinus antrostomyOFFSIDES
293SinusitisOFFSIDES
294Skin IndurationOFFSIDES
295Skin lesionOFFSIDES
296Skin necrosisOFFSIDES
297Skin test positiveOFFSIDES
298Skin tightnessOFFSIDES
299SpondylolisthesisOFFSIDES
300Sputum culture positiveOFFSIDES
301Staphylococcal impetigoOFFSIDES
302Stevens-Johnson SyndromeOFFSIDES
303SubileusOFFSIDES
304Supraventricular tachyarrhythmiaOFFSIDES
305Synovial CystOFFSIDES
306Tooth ExtractionOFFSIDES
307UlcerOFFSIDES
308Venous InsufficiencyOFFSIDES
309Ventricular FibrillationOFFSIDES
310Viral pharyngitisOFFSIDES
311Vision Disorders15550136CTD
312XerosisOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.